Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. 1990.

Spies T, Bresnahan M, Bahram S, Arnold D, Blanck G, Mellins E, Pious D, DeMars R.

J Immunol. 2008 Mar 1;180(5):2737-40. No abstract available.

3.
6.

Invariant-cognate peptide exchange restores class II dimer stability in HLA-DM mutants.

Monji T, McCormack AL, Yates JR 3rd, Pious D.

J Immunol. 1994 Nov 15;153(10):4468-77.

PMID:
7525705
7.
8.

A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides.

Mellins E, Cameron P, Amaya M, Goodman S, Pious D, Smith L, Arp B.

J Exp Med. 1994 Feb 1;179(2):541-9.

9.

A gene required for class II-restricted antigen presentation maps to the major histocompatibility complex.

Mellins E, Kempin S, Smith L, Monji T, Pious D.

J Exp Med. 1991 Dec 1;174(6):1607-15.

10.
11.

Mutations affecting antigen processing impair class II-restricted allorecognition.

Cotner T, Mellins E, Johnson AH, Pious D.

J Immunol. 1991 Jan 15;146(2):414-7.

PMID:
1987270
12.

A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway.

Spies T, Bresnahan M, Bahram S, Arnold D, Blanck G, Mellins E, Pious D, DeMars R.

Nature. 1990 Dec 20-27;348(6303):744-7.

PMID:
2259384
13.

Point mutations define positions in HLA-DR3 molecules that affect antigen presentation.

Mellins E, Arp B, Singh D, Carreno B, Smith L, Johnson AH, Pious D.

Proc Natl Acad Sci U S A. 1990 Jun;87(12):4785-9. Erratum in: Proc Natl Acad Sci U S A 1990 Sep;87(17):6928.

14.

Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes.

Mellins E, Smith L, Arp B, Cotner T, Celis E, Pious D.

Nature. 1990 Jan 4;343(6253):71-4.

PMID:
1967485
15.
16.

Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding.

Clayton LK, Sieh M, Pious DA, Reinherz EL.

Nature. 1989 Jun 15;339(6225):548-51.

PMID:
2543930
17.
18.
19.

Two distinct genetic loci regulating class II gene expression are defective in human mutant and patient cell lines.

Yang Z, Accolla RS, Pious D, Zegers BJ, Strominger JL.

EMBO J. 1988 Jul;7(7):1965-72.

20.

Expression of HLA-DR antigen in human class II mutant B-cell lines by double infection with retrovirus vectors.

Yang Z, Korman AJ, Cooper J, Pious D, Accolla RS, Mulligan RC, Strominger JL.

Mol Cell Biol. 1987 Nov;7(11):3923-8.

21.
22.

Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex.

Spies T, Morton CC, Nedospasov SA, Fiers W, Pious D, Strominger JL.

Proc Natl Acad Sci U S A. 1986 Nov;83(22):8699-702.

23.

Evidence for two trans-acting genes regulating HLA class II antigen expression.

Salter RD, Alexander J, Levine F, Pious D, Cresswell P.

J Immunol. 1985 Dec;135(6):4235-8.

PMID:
3934280
24.

HLA class II regulation and structure. Analysis with HLA-DR3 and HLA-DP point mutants.

Pious D, Dixon L, Levine F, Cotner T, Johnson R.

J Exp Med. 1985 Oct 1;162(4):1193-207.

25.

Clonal T lymphocyte recognition of the fine structure of the HLA-A2 molecule.

Brenner MB, McLean J, Yang SY, van der Poel JJ, Pious D, Strominger JL.

J Immunol. 1985 Jul;135(1):384-90.

PMID:
2582041
26.

Deletion mapping of HLA and chromosome 6p genes.

Levine F, Erlich H, Mach B, Leach R, White R, Pious D.

Proc Natl Acad Sci U S A. 1985 Jun;82(11):3741-5.

27.

Transcriptional regulation of HLA class II and invariant chain genes.

Levine F, Erlich HA, Mach B, Pious D.

J Immunol. 1985 Jan;134(1):637-40.

PMID:
3964823
28.

Different roles for cytosine methylation in HLA class II gene expression.

Levine F, Pious D.

Immunogenetics. 1985;22(5):427-40.

PMID:
2998981
29.

Characterization of a B lymphoblastoid cell line mutant that secretes HLA-A2.

Krangel MS, Pious D, Strominger JL.

J Immunol. 1984 Jun;132(6):2984-91.

PMID:
6609965
30.
31.

Mutant HLA-A2 antigens as restricting elements for virus-specific cytotoxic T cells.

Gaston JS, Wallace LE, Rickinson AB, Epstein MA, Pious D.

Immunogenetics. 1984;19(6):475-86.

PMID:
6329950
32.
33.

Recognition of HLA-A2 mutant and variant target cells by an HLA-A2 allospecific human cytotoxic T lymphocyte line.

Ware CF, Krangel MS, Pious D, Burakoff SJ, Strominger JL.

J Immunol. 1983 Sep;131(3):1312-7.

PMID:
6193184
34.

Mapping of the genes encoding the HLA-DR alpha chain and the HLA-related antigens to a chromosome 6 deletion by using genomic blotting.

Erlich HA, Stetler D, Saiki R, Gladstone P, Pious D.

Proc Natl Acad Sci U S A. 1983 Apr;80(8):2300-4.

35.
36.

HLA antigen structural gene mutants selected with an allospecific monoclonal antibody.

Pious D, Krangel MS, Dixon LL, Parham P, Strominger JL.

Proc Natl Acad Sci U S A. 1982 Dec;79(24):7832-6.

38.

Gene dosage and gene expression in the HLA region: evidence from deletion variants.

Gladstone P, Fueresz L, Pious D.

Proc Natl Acad Sci U S A. 1982 Feb;79(4):1235-9.

39.
40.

Monoclonal antibodies as a tool for phylogenetic studies of major histocompatibility antigens and beta 2-microglobulin.

Teillaud JL, Crevat D, Chardon P, Kalil J, Goujet-Zalc C, Mahouy G, Vaiman M, Fellous M, Pious D.

Immunogenetics. 1982;15(4):377-84.

PMID:
6176537
41.

Regulation of expression of MHC gene products: evidence from HLA variants.

Pious D, Gladstone P.

Transplant Proc. 1981 Dec;13(4):1800-3. No abstract available.

PMID:
6949384
42.

HLA variants of human lymphoblastoid cell lines as targets for cytotoxic T cells: analysis of CTL reactivity against 2 HLA-DR variants.

Newman W, Pious D, Gladstone P.

J Immunol. 1980 Dec;125(6):2515-20. No abstract available.

PMID:
6968788
43.

Linked marker analysis of spontaneous HLA variants of somatic cells.

Pious D, Martin S, Gladstone P, Soderland C.

Somatic Cell Genet. 1980 Jul;6(4):529-41.

PMID:
6969452
44.
46.

Variation in S phase in synchronous human cell lines.

Kapp LN, Millis AJ, Pious DA.

In Vitro. 1979 Sep;15(9):669-72.

PMID:
161285
47.

Approaches to the prevention of congenital malformations of the central nervous system.

Pious D.

Birth Defects Orig Artic Ser. 1979;15(3):105-16. No abstract available.

PMID:
380679
48.

The firstH- 2 mutant workshop.

Kohn HI, Klein J, Melvold RW, Nathenson SG, Pious D, Shreffler DC.

Immunogenetics. 1978 Dec;7(1):279-94. doi: 10.1007/BF01844019.

PMID:
21302084
49.

Production in vitro of murine antibody to a human histocompatibility alloantigen.

Lampson LA, Levy R, Grumet FC, Ness D, Pious D.

Nature. 1978 Feb 2;271(5644):461-2. No abstract available.

PMID:
564458
50.

Stable variants affecting B cell alloantigens in human lymphoid cells.

Gladstone, Pious D.

Nature. 1978 Feb 2;271(5644):459-61. No abstract available.

PMID:
75508

Supplemental Content

Support Center